Literature DB >> 22559128

The puzzle of schizophrenia: tracking the core role of cognitive deficits.

Keith H Nuechterlein1, Kenneth L Subotnik, Joseph Ventura, Michael F Green, Denise Gretchen-Doorly, Robert F Asarnow.   

Abstract

Cognitive deficits in schizophrenia are increasingly accepted as core features of this disorder that play a role as vulnerability indicators, as enduring abnormalities during clinical remission, and as critical rate-limiting factors in functional recovery. This article demonstrates the lasting influence of Norman Garmezy through his impact on one graduate student and then through his later collaborative research with colleagues. The promise of core cognitive deficits as vulnerability indicators or endophenotypes was demonstrated in research with children born to a parent with schizophrenia as well as with biological parents and siblings of individuals with schizophrenia. In studies of patients with a recent onset of schizophrenia, cognitive deficits were found to endure across psychotic and clinically remitted periods and to have a strong predictive influence on likelihood of returning successfully to work or school. Converging lines of evidence for the enduring core role of cognitive deficit in schizophrenia have led in recent years to a burgeoning interest in developing new interventions that target cognition as a means of improving functional recovery in this disorder.

Entities:  

Mesh:

Year:  2012        PMID: 22559128     DOI: 10.1017/S0954579412000132

Source DB:  PubMed          Journal:  Dev Psychopathol        ISSN: 0954-5794


  8 in total

1.  Metacognition as a Mediating Variable Between Neurocognition and Functional Outcome in First Episode Psychosis.

Authors:  Geoff Davies; David Fowler; Kathryn Greenwood
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

3.  Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.

Authors:  Steven M Silverstein; Yushi Wang; Brian P Keane
Journal:  Front Psychol       Date:  2013-01-21

4.  Behavioral and cognitive changes after early postnatal lesions of the rat mediodorsal thalamus.

Authors:  Zakaria Ouhaz; Saadia Ba-M'hamed; Anna S Mitchell; Abdeslem Elidrissi; Mohamed Bennis
Journal:  Behav Brain Res       Date:  2015-06-12       Impact factor: 3.332

5.  Neurocognitive Functioning in Schizophrenia, their Unaffected Siblings and Healthy Controls: A Comparison.

Authors:  Ritu Nehra; Sandeep Grover; Sunil Sharma; Aditi Sharma; Natasha Kate
Journal:  Indian J Psychol Med       Date:  2016 Jan-Feb

6.  Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients.

Authors:  Priyanthi B Gjerde; Carmen E Simonsen; Trine V Lagerberg; Nils E Steen; Torill Ueland; Ole A Andreassen; Vidar M Steen; Ingrid Melle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-27       Impact factor: 5.270

7.  Abnormal emotion processing, but intact fairness and intentionality considerations during social decision-making in schizophrenia.

Authors:  Javier de la Asuncion; Lise Docx; Bernard Sabbe; Manuel Morrens; Ellen R A de Bruijn
Journal:  Front Psychol       Date:  2015-07-23

8.  Superior memory performance in healthy individuals with subclinical psychotic symptoms but without genetic load for schizophrenia.

Authors:  G Gagnon; S Kumar; J-R Maltais; A N Voineskos; B H Mulsant; T K Rajji
Journal:  Schizophr Res Cogn       Date:  2018-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.